Plus   Neg

JPMorgan CEO Expects Growth Opportunities 'almost Everywhere'

JPMorgan Chase & Co.'s (JPM) Chief Executive Officer Jamie Dimon said that he expects opportunities for the company to expand "almost everywhere" -- including in businesses where it's already dominant and one that's been particularly tough across the industry in recent years.

In an annual letter to shareholders, Dimon said, "We see growth opportunities even in Fixed Income, Currencies and Commodities, where we already have the #1 market share at 11.4%. There may be some underlying growth as the capital markets of the world grow, even though this is partially offset by declining margins like we have experienced over the last 30 years. However, we see opportunities to gain share in various products and in certain regions where we have low share."

In other areas -- such as investment banking, asset management and consumer and commercial banking -- the bank plans to hire, add branches, enter new markets or roll out new technology, he said.

JPMorgan Chase plans to build up to 400 Chase branches in 15-20 new markets and hire up to 4,000 additional employees over the next five years. The employees will support branch growth and more lending to small businesses and homeowners.

He said the company currently has excess capital, but due to recent tax reform and a more constructive regulatory environment, the company hopes, in the future, to use more of excess capital to grow businesses, expand into new markets and support employees.

Dimon said,"We need to form a bipartisan group of experts whose direct charge is to fix our healthcare system. I am convinced that this can be done, and if done properly, it will actually improve the outcomes and satisfaction of all American citizens."

Dimon said,"As for JPMorgan Chase, fortunately, we have the resources to be prepared for a hard Brexit, as we must be. It essentially means moving 300-400 jobs around Europe in the short term and modifying some of our legal entities to be able to conduct business the day after Brexit."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT